Home » Topics » Regulatory

Regulatory
RSS

Uroxatral launched in U.S.

Nov. 5, 2003

Pfizer submits sNDA for Geodon for acute bipolar mania

Nov. 3, 2003

Seroquel deemed approvable by the FDA

Nov. 3, 2003

Risperdal Consta receives FDA approval

Nov. 3, 2003

Synagis approved for expanded use in Europe

Nov. 3, 2003

Canadian approval for Gleevec for newly diagnosed Ph+ CML

Oct. 30, 2003

Raptiva approved for chronic, moderate to severe plaque psoriasis

Oct. 30, 2003

Levaquin approved for five-day treatment of CAP

Oct. 30, 2003

Cyberonics submits PMA-S for VNS Therapy

Oct. 29, 2003

Remicade approved in E.U. for maintenance dosing in fistulizing Crohn's disease

Oct. 27, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...